ClinConnect ClinConnect Logo
Search / Trial NCT06739109

Guided Internet-Based Treatment for Harmful Alcohol Use; EBehandling Alkohol

Launched by SYKEHUSET I VESTFOLD HF · Dec 12, 2024

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Internet Based Treatment Guided Internet Treatment Alcohol Use

ClinConnect Summary

This clinical trial, called eBehandling Alkohol (eBA), is studying a new online treatment program designed to help people who struggle with harmful alcohol use. Starting in autumn 2024, this program will be available at five hospitals. The goal is to see how effective this internet-based treatment is in reducing alcohol use and improving overall health and well-being. Previous studies have shown promising results, indicating that this type of treatment can be helpful for many individuals, particularly those who may feel embarrassed or reluctant to seek help in traditional settings.

To participate, individuals must be aged 18 and older, have harmful alcohol use, and be willing to work on reducing their drinking. They should also be comfortable using the internet and have access to a computer, tablet, or smartphone. Importantly, there’s no need for a referral from a doctor to join. After an initial screening, participants will complete nine online treatment modules over the course of 8 to 12 weeks. During this time, and for two years after completing the program, participants will receive follow-up support and answer questions about their progress. This trial aims to help develop better treatment options for those facing alcohol-related issues and is part of a larger effort to understand how internet-based treatments can be more widely used.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Harmful alcohol use
  • Willing to make an effort to reduce alcohol consumption
  • Able to use guided internet-based treatment
  • Access to a computer, tablet, or smartphone
  • Access to BankID or equivalent secure log-in
  • Exclusion Criteria:
  • \* Acute and/or severe mental disorders, such as psychotic issues or ongoing suicidal issues.

About Sykehuset I Vestfold Hf

Sykehuset i Vestfold HF is a leading healthcare institution located in Vestfold, Norway, dedicated to providing high-quality medical care and advancing clinical research. As a prominent clinical trial sponsor, the organization is committed to enhancing patient outcomes through innovative research initiatives and collaboration with various stakeholders in the medical and scientific communities. With a focus on ethical standards and regulatory compliance, Sykehuset i Vestfold HF aims to contribute to the development of new therapies and treatment protocols, ensuring that its research efforts are aligned with the needs of patients and the broader healthcare landscape.

Locations

Trondheim, , Norway

Tønsberg, Vestfold, Norway

Loerenskog, Akershus, Norway

Trondheim, Trøndelag, Norway

Kristiansand, Agder, Norway

Lillehammer, Innlandet, Norway

Patients applied

0 patients applied

Trial Officials

Kristin K Solli, PhD

Principal Investigator

Sykehuset i Vestfold HF

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported